The biomarker ciRS-7 reduces epidermal growth factor receptor (EGFR-RAF1) activity in colon cancer patients and promotes growth and metastasis of esophageal squamous cell carcinoma via miR-7/HOXB13 (36, 37). Here, HOXB13 is linked to malignant colon neoplasm.